Pharmaceutical giants Merck & Co. and Pfizer Inc. were kings of the Dow Jones industrial index during the year, while Eli Lilly and Co. was among the 20 largest gainers on the S&P 500.
Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
Drug industry analysts on Monday applauded Eli Lilly and Co.’s pending $8 billion cash deal to buy a startup that focuses on oncology, which has become a prime focus for the pharma giant in the last year.
Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will begin promoting a website where prices are available.
A prolonged shutdown could muddle Eli Lilly and Co.’s plan to unload its stake in Elanco Animal Health Inc., the unit it spun off last year, Lilly CEO Dave Ricks said.
A trio of jocks and computer geeks from Rose-Hulman Institute of Technology has produced computer software that has had a major impact on the top level of college baseball and softball. Now the small, self-funded firm is making a big play in the NFL with data analytics.
The Catalyst Award recognizes companies that excel in addressing recruitment, development and advancement of women. Today, nearly half of Lilly's senior leadership is female, up from 20 percent four years ago.
Now that Bates-Hendricks has emerged as one of the city’s housing hot spots, its neighborhood association is focusing on the commercial boom residents believe will follow.
Analysts had predicted that Lartruvo could eventually ring up as much as $600 million in annual sales. Eli Lilly and Co. now says it will suspend promotion of the drug.
Jose Evans has decided to not to run for mayor and has thrown his support behind State Sen. Jim Merritt. And City-County Council member Jefferson Shreve, who replaced Jeff Miller last year, won’t seek a return to the council after his current term ends.
Lartruvo shouldn’t be started in new patients, and those patients already taking it should ask their doctors if they should continue, U.S. regulators said, following a key study that failed to show the medicine prolonged lives.
Sen. Ron Wyden, the ranking Democrat on the committee, singled out Humalog, an insulin made by Indianapolis-based Eli Lilly and Co, as a drug with unwarranted price hikes.
Increasingly, top researchers are questioning whether drugs such as Lantus from Sanofi, Levemir and Novolog from Novo Nordisk A/S, and Humalog from Eli Lilly and Co. are really needed for many patients.
The soaring Hispanic population can be a powerful engine for growth in the Indiana economy—potential that some of the state’s best-known businesses are embracing.
The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers.
The Indianapolis drugmaker said the drug, baricitinib, proved effective in treating adults with a severe form of eczema. It’s the latest turn for a drug that has had repeated setbacks.
The Indianapolis-based pharmaceutical giant on Wednesday tempered expectations for its earnings in 2019 after a promising cancer drug failed to pan out and the firm prepared for big acquisition.
When the Indianapolis-based drug giant made its initial offer Dec. 20, it said it wanted to seal the deal before the J.P. Morgan Healthcare Conference, which ran Jan. 7-10 in San Francisco.
Greenfield-based Elanco spun off from Lilly last fall after 53 years. The former parent company still owns 80.2 percent of Elanco stock but has announced a program to unload it.
